Terminated PHASE1 INTERVENTIONAL 1-arm NCT04025307

Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours

A Multi-centre, Open-label, Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours

Sponsor: Iqvia Pty Ltd

Conditions Cancer - Solid Tumours

Interventions bacTRL-IL-12

Updated 6 times since 2019 Last updated: Mar 10, 2021 Started: Aug 5, 2019 Primary completion: Dec 29, 2020 Completion: Dec 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other terminated trials from Iqvia Pty Ltd

More terminations from Iqvia Pty Ltd

This PHASE1 trial investigates Cancer - Solid Tumours and is currently terminated or withdrawn. Iqvia Pty Ltd leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Apr 2021 — Jul 2024 [monthly]

Terminated PHASE1

Status: Recruiting → Terminated
Jan 2021 — Apr 2021 [monthly]

Recruiting PHASE1
Apr 2020 — Jan 2021 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Aug 2019 — Apr 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Iqvia Pty Ltd

Data source: Iqvia Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia